Cadila Pharmaceuticals launches Cadalimab™(Adalimumab biosimilar) for India. Adalimumabis a disease-modifying antirheumatic drug and a monoclonal antibody that works by inactivating tumor necrosis factor-alpha (TNFα) recommended in the treatment of many
